CMS Five-Star Quality Rating System Identifies Satellite Healthcare as Leading 10 Largest Dialysis Providers in Percentage of Top-Rated Dialysis Centers
October 27, 2016 15:31 ET
|
Satellite Healthcare
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare today announced that it leads the industry with the highest percentage of top-rated dialysis centers among the 10 largest...
Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors
October 20, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
September 01, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Satellite Healthcare Partners with American Kidney Fund to Support Clinical Research
August 15, 2016 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that it has joined forces with the American Kidney...
Satellite Healthcare Congratulates 2016 Coplon Grant Recipients
August 11, 2016 09:00 ET
|
Satellite Healthcare
SAN JOSE, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce the recipients of the 2016 Norman S. Coplon...
Proteon Therapeutics Announces Second Quarter 2016 Financial Results
August 08, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd
June 15, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients...
Proteon Therapeutics Announces First Quarter 2016 Financial Results
May 09, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 09, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis Patients
April 28, 2016 07:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results
March 14, 2016 08:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...